Latest Asx News

Omnia Metals Group has finalized its $1.58 million placement with the issue of 25 million shares and over 70 million options, setting the stage for renewed exploration and strategic growth.

Truscott Mining Corporation has successfully raised $1.44 million through a placement, issuing 27 million new securities, and plans to kick off drilling activities early next year.

Southern Cross Media Group has secured legal approval to acquire Seven West Media, marking a significant consolidation in Australia's media landscape. Seven West Media shares will be suspended as the scheme moves to implementation.

Tambourah Metals has confirmed and significantly upgraded gold assay results from its Beatty Park South drilling, highlighting a high-grade core within a 330m gold anomaly at its Bryah Gold Project in Western Australia.

Comms Group Limited has finalized a new three-year debt refinancing agreement with Westpac, improving its financial flexibility and positioning for future acquisitions.

The Supreme Court of New South Wales has approved the acquisition of Seven West Media by Southern Cross Media, marking a major consolidation in Australian media. SWM shares will be suspended from trading as shareholders prepare to receive Southern Cross shares in early January.

Dome Gold Mines reports a substantial 19.9 million tonne construction sand resource at its Sigatoka project, alongside a key board appointment and licence renewal that advance its mining ambitions.

Proteomics International Laboratories has achieved the prestigious CAP accreditation for its US lab and installed a new mass spectrometry platform, setting the stage for the 2026 launch of its Promarker diagnostic tests in America.

Kalamazoo Resources has appointed Adam Garczynski to lead the Mt Olympus Pre-Feasibility Study and completed the first diamond drill hole at its Ashburton Gold Project, marking key progress in its 2026 development plans.

Clarity Pharmaceuticals’ novel diagnostic agent Cu-SAR-bisPSMA has been selected for oral presentation at the prestigious European Association of Urology Congress 2026, following promising Phase II trial results demonstrating superior detection of prostate cancer recurrence.

RocketBoots Limited has successfully raised A$7 million through a placement to accelerate its international expansion following a transformative global contract. The capital injection aims to scale its AI-driven loss-prevention platform and convert a robust enterprise pipeline.

Enlitic has locked in commitments for an A$8 million convertible note capital raise, with initial funds arriving immediately and the remainder pending shareholder approval. This funding aims to extend the company’s runway as it advances its AI-driven healthcare solutions.